Open access
Jul 2026
ICBcDrug: An online resource and tool for screening and predicting immunotherapy combination drugs.
ICBcDrug is a freely accessible and valuable resource for advancing ICB combination therapy that integrates 2311 reported or predicted compounds across 18 cancer types and accurately predicted both the efficacy and potential mechanisms of the known ICB enhancer entinostat.
Yu Lin, Wen Sun, Yun Xia et al.
· Chinese Medical Journal · 0 citations